AIGH Capital Management LLC In its 13F for Q4 2024 (holdings as of December 31, 2024, filed February 12, 2025), AIGH Capital Management LLC reported 36 stock positions worth $265.7 million . Its top holding was Personalis (PSNL) at 8.3% of the portfolio, followed by Myomo (MYO, 8.2% ) and Arq (ARQ, 8.0% ). Compared with Q3 2024, it opened 7 new positions, sold out of 8, added to 14 and reduced 7. The biggest buy was a new position in Marvell Technology (MRVL) and the biggest sale an exit from Digital Turbine (APPS).
Location BALTIMORE, MD
CIK 0001835943
Portfolio Value $265.7M (Q4 2024) Holdings 36 stocks · $265.7M Holdings quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock % Of Portfolio ▼ Shares Held Total Value Change vs Q3 2024 PSNL Personalis Inc. 3,799,064 $22.0M Reduce -5.0% MYO Myomo Inc. 3,381,567 $21.8M Add +21.7% ARQ Arq Inc. 2,817,078 $21.3M No change DCTH Delcath Systems Inc. 1,385,389 $16.7M Reduce -22.3% MRVL Marvell Technology Inc. 150,000 $16.6M New SCPH Scpharmaceuticals Inc. 4,174,367 $14.8M Add +1.2% VSTM Verastem Inc. 2,665,043 $13.8M New LPTH Lightpath Technologies Inc. Class A 3,723,932 $13.1M No change TARS Tarsus Pharmaceuticals Inc. 224,713 $12.4M Add +9.9% ELUT Elutia Inc. 3,074,675 $11.5M Add +22.5% BLZE Backblaze Inc. Class A 1,800,000 $10.8M New BDSX Biodesix Inc. 6,179,812 $9.5M Add +8.8% BKTI BK Technologies Corp. 268,180 $9.2M Reduce -5.2% XERS Xeris Biopharma Holdings Inc. 2,574,846 $8.7M Add +17.8% TELA Tela Bio Inc. 2,662,785 $8.0M Add +7.8% COYA Coya Therapeutics Inc. 1,201,152 $6.9M Add +85.0% ZVRA Zevra Therapeutics Inc. 788,614 $6.6M New ELVA Electrovaya Inc. 2,525,099 $6.3M Add +3.2% IPWR Ideal Power Inc. 823,315 $6.2M Add +17.6% THTX Theratechnologies Inc. 3,026,569 $5.5M Reduce -18.8% IDN Intellicheck Inc. 1,617,696 $4.5M Reduce -8.5% GLW Corning Inc. 75,000 $3.6M Reduce -66.7% PYPD Polypid Ltd. 827,867 $2.5M Add +21.8% GRCE Grace Therapeutics Inc. 521,083 $2.0M New FKWL Franklin Wireless Corp. 390,000 $1.9M No change APRE Aprea Therapeutics Inc. 539,300 $1.8M No change INAB IN8BIO Inc. 6,191,865 $1.6M Add +269.7% INO Inovio Pharmaceuticals Inc. 654,115 $1.2M New BFRI Biofrontera Inc. 811,097 $884K Add +61.8% KPRX Kiora Pharmaceuticals Inc. 255,555 $850K No change KALA Kala Bio Inc. 121,302 $842K New CNSY Plus Therapeutics Inc. 560,905 $645K No change BIOMX INC 865,400 $632K No change SMTK Smartkem Inc. 156,487 $456K Add +16.2% XAIR Beyond Air Inc. 991,476 $355K Reduce -72.5% MCHX Marchex Inc. Class B 198,100 $347K No change
Options reported separately and not counted above: GLW calls ($32.1M), MRVL calls ($22.1M).
Portfolio Sells Q3 2024 → Q4 2024 Portfolio Sells quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q3 2024 % Of Portfolio Change To Portfolio ▲ APPS Digital Turbine Inc. Sold out 0.00% −6.45 GLW Corning Inc. Reduce -66.7% 1.34% −3.41 CLRB Cellectar Biosciences Inc. Sold out 0.00% −3.20 EGRX Eagle Pharmaceuticals Inc. Sold out 0.00% −2.12 PSNL Personalis Inc. Reduce -5.0% 8.27% −1.81 DCTH Delcath Systems Inc. Reduce -22.3% 6.28% −1.26 MRAM Everspin Technologies Inc. Sold out 0.00% −1.03 MX Magnachip Semiconductor Corp. Sold out 0.00% −0.98 ACASTI PHARMA INC Sold out 0.00% −0.90 IMMX Immix Biopharma Inc. Sold out 0.00% −0.78 XAIR Beyond Air Inc. Reduce -72.5% 0.13% −0.51 EVOK Evoke Pharma Inc. Sold out 0.00% −0.16 THTX Theratechnologies Inc. Reduce -18.8% 2.06% −0.10 IDN Intellicheck Inc. Reduce -8.5% 1.71% −0.09 BKTI BK Technologies Corp. Reduce -5.2% 3.46% +0.58
Portfolio Buys Q3 2024 → Q4 2024 Portfolio Buys quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q3 2024 % Of Portfolio Change To Portfolio ▼ MRVL Marvell Technology Inc. New 6.24% +6.24 VSTM Verastem Inc. New 5.19% +5.19 BLZE Backblaze Inc. Class A New 4.08% +4.08 MYO Myomo Inc. Add +21.7% 8.20% +2.98 ZVRA Zevra Therapeutics Inc. New 2.48% +2.48 TARS Tarsus Pharmaceuticals Inc. Add +9.9% 4.68% +1.54 GRCE Grace Therapeutics Inc. New 0.74% +0.74 COYA Coya Therapeutics Inc. Add +85.0% 2.59% +0.63 INO Inovio Pharmaceuticals Inc. New 0.45% +0.45 INAB IN8BIO Inc. Add +269.7% 0.60% +0.39 XERS Xeris Biopharma Holdings Inc. Add +17.8% 3.29% +0.37 KALA Kala Bio Inc. New 0.32% +0.32 TELA Tela Bio Inc. Add +7.8% 3.03% +0.10 BFRI Biofrontera Inc. Add +61.8% 0.33% +0.02 SMTK Smartkem Inc. Add +16.2% 0.17% −0.10 ELUT Elutia Inc. Add +22.5% 4.33% −0.15 PYPD Polypid Ltd. Add +21.8% 0.94% −0.16 ELVA Electrovaya Inc. Add +3.2% 2.36% −0.32 IPWR Ideal Power Inc. Add +17.6% 2.34% −0.35 BDSX Biodesix Inc. Add +8.8% 3.56% −1.17 SCPH Scpharmaceuticals Inc. Add +1.2% 5.56% −3.24
Options Activity Q3 2024 → Q4 2024 Security Type Change vs Q3 2024 Underlying Shares Value ▼ XBI SS SPDR S&P Biotech ETF put Sold out 500,000 $110.4Mbefore exit MRVL Marvell Technology Inc. call New 200,000 $22.1M
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
Notes & Other Activity Q3 2024 → Q4 2024 Security Class Change vs Q3 2024 Shares / Principal Value ▼ SVREW Saverone 2014 Ltd. -CW27 *W EXP 06/02/202 Sold out 568,194 $45Kbefore exit
Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.
All Filings Quarter Positions 13F Reported Value Top Holdings Q2 2026 42 $1.1B SNDK, MXL, INTC, APPS, SIMO Q1 2026 40 $488.3M SNDK, TYGO, SIMO, ZBRA, LASR Q4 2025 31 $338.3M SNDK, CSTL, PSNL, LASR, DAWN Q3 2025 34 $285.6M SNDK, PSNL, HUCK, ARQ, MXL Q2 2025 34 $213.1M PSNL, HUCK, SCPH, ARQ, VPG Q1 2025 38 $192.7M VSTM, MYO, PSNL, ARQ, SCPH Q4 2024 36 $265.7M PSNL, MYO, ARQ, DCTH, MRVL Q3 2024 37 $213.6M PSNL, SCPH, ARQ, DCTH, APPS Q2 2024 35 $204.9M SIMO, INFN, DCTH, SCPH, ARQ Q1 2024 39 $207.3M SCPH, OUST, ELVA, CLRB, DCTH